Biography
Peter is a Rheumatologist & Immunologist who immerses himself in basic & clinical research. He received his medical degree from the New York University School of Medicine, completed residency training at the Strong Memorial Hospital in Rochester, New York and his post-doctoral fellowship in NIAID at the NIH. After going to UT Southwestern Medical Center at Dallas, Peter rapidly advanced to become a professor of Internal Medicine and Microbiology as well as the Director of the Harold C Simmons Arthritis Research Center and, Co-Director of the Immunology Graduate Program. He entered the new millennium as the Director of the Intramural Research Program & the Autoimmunity Branch of NIAMS at the NIH. Peter is the co-founder and CEO of AMPEL BioSolutions LLC, a biotech company involved in employing analysis of BigData and Machine Learning to provide personalized medicine. Peter is the former editor of the Journal of Immunology, Nature Reviews Rheumatology and Arthritis Research & Therapy, and is the recipient of the Carol Nachman Prize, the American College of Rheumatology Distinguished Investigator Award and the Arthritis Foundation’s Lee Howley prize.

Biography
Mika has more than 20 years of commercial strategy and leadership experience in life sciences, with a focus on novel technologies. Over the last 10 years, Mika has concentrated on evidence-based medicine and tools to transform healthcare and clinical development. Before joining xCures Mika was the Chief Commercial Officer of Doctor Evidence, LLC. Prior to Doctor Evidence he was the General Manager of Clinical Development Services at diaDexus, SVP of Client and Market Development at Evidera, VP of Sales and Marketing at Archimedes, and held sales management and sales operations roles at Quintiles, Invitrogen and Tripos.

Biography
William K. Oh, M.D. is Chief Medical Science Officer at Sema4, a patient-centered health intelligence company focused on precision medicine. He is also an internationally recognized medical oncologist with over 25 years of clinical and translational research experience and leadership roles at major NCI-designated cancer centers. He continues to see cancer patients in his capacity as Clinical Professor of Medicine at Icahn School of Medicine at Mount Sinai. William has authored more than 330 articles, reviews, books and book chapters related to genitourinary cancers. He has conducted multiple clinical cancer trials and has served in key invited roles for the American Society of Clinical Oncology, the American Cancer Society, and the American Urological Association.

AI & Data Science Showcase:
Sema4
Sema4 is a Patient-Centered Health Intelligence Company Leveraging AI, Genomics and Other Deep Data.

REPRESENT: Providing Prec. Oncology Access to All
Sema4 launched the REPRESENT study in community oncology practices caring for patients with advanced cancer in diverse, underserved populations. REPRESENT will perform comprehensive genomic profiling, hereditary cancer testing and clinical data including SDOH and correlate outcomes to these findings.

Biography
Nasim leads the applied AI and data science department at City of Hope, one of the largest cancer research and treatment organizations in the United States. She helps supervise teams that are responsible for applying machine learning in clinical decision support and patient care, research, and precision medicine, as well as operations and finance. Before joining City of Hope in 2017, Nasim co-founded an AI company focusing on social media data mining and financial markets and political events prediction. She continues to advise startup companies on successful implementation of AI solutions. Nasim holds a master’s degree in computer science from Southern Illinois University and a bachelor’s degree in computer engineering from Khaje Nasir Toosi University in Tehran, Iran. On a personal level, Nasim enjoys an active lifestyle in sunny Los Angeles and has a passion for fitness and sports. She plays soccer and beach volleyball and goes to the gym every day!